{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:01:08Z","timestamp":1769763668711,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002956","name":"Foundation for Women's Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ebiom.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T14:08:40Z","timestamp":1557410920000},"page":"261-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["CCAAT\/enhancer binding protein delta (C\/EBP\u03b4) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Ramlogan","family":"Sowamber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Chehade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah V.","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Milea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-1883","authenticated-orcid":false,"given":"Sophia H.L.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2019.05.002_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.ebiom.2019.05.002_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ebiom.2019.05.002_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.PGP.0000079451.72325.63","article-title":"Women harboring BRCA1\/2 germline mutations are at risk for breast and female adnexal carcinoma","volume":"22","author":"Piek","year":"2003","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.05.002_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.ebiom.2019.05.002_bb0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian tube lesions in women at high risk for ovarian Cancer: a Multicenter study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.ebiom.2019.05.002_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/onc.2015.62","article-title":"Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis","volume":"35","author":"George","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2014.00005","article-title":"BRCA and early events in the development of serous ovarian Cancer","volume":"4","author":"George","year":"2014","journal-title":"Front Oncol"},{"issue":"18","key":"10.1016\/j.ebiom.2019.05.002_bb0050","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2019.05.002_bb0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.ebiom.2019.05.002_bb0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase","volume":"23","author":"Sehdev","year":"2010","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2019.05.002_bb0065","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.05.002_bb0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2013.218","article-title":"Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma","volume":"27","author":"Milea","year":"2014","journal-title":"Mod Pathol"},{"issue":"35","key":"10.1016\/j.ebiom.2019.05.002_bb0080","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1038\/onc.2013.394","article-title":"FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis","volume":"33","author":"Levanon","year":"2014","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.ebiom.2019.05.002_bb0085","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"7353","key":"10.1016\/j.ebiom.2019.05.002_bb0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas N","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2019.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin e1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/modpathol.2011.67","article-title":"Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma","volume":"24","author":"Kuhn","year":"2011","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.05.002_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.6004\/jnccn.2015.0105","article-title":"Breast Cancer risk reduction, version 2.2015","volume":"13","author":"Bevers","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"0","key":"10.1016\/j.ebiom.2019.05.002_bb0115","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"0","author":"Wu","year":"2018","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.05.002_bb0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2019.05.002_bb0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-012-9351-2","article-title":"Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis","volume":"31","author":"Sodek","year":"2012","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/path.2927","article-title":"Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers","volume":"225","author":"George","year":"2011","journal-title":"J Pathol"},{"issue":"Pt 3","key":"10.1016\/j.ebiom.2019.05.002_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj20020508","article-title":"CCAAT\/enhancer-binding proteins: structure, function and regulation","volume":"365","author":"Ramji","year":"2002","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.ebiom.2019.05.002_bb0140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7150\/ijbs.7224","article-title":"The many faces of C\/EBP\u03b4 and their relevance for inflammation and Cancer","volume":"9","author":"Balamurugan","year":"2013","journal-title":"Int J Biol Sci"},{"issue":"33","key":"10.1016\/j.ebiom.2019.05.002_bb0145","doi-asserted-by":"crossref","first-page":"28662","DOI":"10.1074\/jbc.M111.270710","article-title":"CCAAT\/enhancer-binding protein \u03b4 mediates tumor necrosis factor \u03b1-induced Aurora kinase C transcription and promotes genomic instability","volume":"286","author":"Wu","year":"2011","journal-title":"J Biol Chem"},{"issue":"7279","key":"10.1016\/j.ebiom.2019.05.002_bb0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","article-title":"The transcriptional network for mesenchymal transformation of brain tumours","volume":"463","author":"Carro","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2019.05.002_bb0155","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.ajpath.2012.01.040","article-title":"The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of Glioblastoma","volume":"180","author":"Cooper","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0160","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.onc.1208393","article-title":"C\/EBP\u03b4 expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation","volume":"24","author":"Gery","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/pros.20159","article-title":"C\/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells","volume":"63","author":"Sanford","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0170","article-title":"Oncostatin M induces growth arrest of mammary epithelium via a CCAAT\/enhancer-binding protein delta-dependent pathway","volume":"1","author":"Hutt","year":"2002","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"10.1016\/j.ebiom.2019.05.002_bb0175","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1158\/1078-0432.CCR-10-1025","article-title":"CEBPD reverses RB\/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells","volume":"16","author":"Pan","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"45","key":"10.1016\/j.ebiom.2019.05.002_bb0180","doi-asserted-by":"crossref","first-page":"30919","DOI":"10.1074\/jbc.M804029200","article-title":"Epigenetic silencing of CCAAT\/enhancer-binding protein \u03b4 activity by YY1\/Polycomb group\/DNA Methyltransferase complex","volume":"283","author":"Ko","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2019.05.002_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-005-9061-3","article-title":"Promoter methylation reduces C\/EBP\u03b4 (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors","volume":"95","author":"Tang","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.ebiom.2019.05.002_bb0190","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1158\/0008-5472.CAN-03-3619","article-title":"CCAAT\/enhancer-binding protein \u03b4: a molecular target of 1,25-Dihydroxyvitamin D3 in androgen-responsive prostate Cancer LNCaP cells","volume":"65","author":"Takayuki Ikezoe","year":"2005","journal-title":"Cancer Res"},{"issue":"1662","key":"10.1016\/j.ebiom.2019.05.002_bb0195","first-page":"1","article-title":"FBXW7\u03b1 attenuates inflammatory signalling by downregulating C\/EBP\u03b4 and its target gene Tlr4","volume":"4","author":"Kuppusamy Balamurugan","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1177\/153537020322800306","article-title":"Nulliparous CCAAT\/enhancer binding protein delta (C\/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia","volume":"228","author":"Gigliotti","year":"2003","journal-title":"Exp Biol Med"},{"issue":"21","key":"10.1016\/j.ebiom.2019.05.002_bb0205","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1242\/dev.02050","article-title":"C\/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution","volume":"132","author":"Thangaraju","year":"2005","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2010.01.006","article-title":"Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary","volume":"117","author":"May","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ebiom.2019.05.002_bb0215","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1158\/1078-0432.CCR-12-2155","article-title":"Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status","volume":"18","author":"George","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"13","key":"10.1016\/j.ebiom.2019.05.002_bb0220","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-07-4959","article-title":"Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma","volume":"14","author":"Tone","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2019.05.002_bb0225","doi-asserted-by":"crossref","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","article-title":"PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification","volume":"38","author":"Spandidos","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"10.1016\/j.ebiom.2019.05.002_bb0230","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1093\/nar\/gng154","article-title":"A PCR primer bank for quantitative gene expression analysis","volume":"31","author":"Wang","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0235","first-page":"272","article-title":"CCAAT\/enhancer-binding protein-delta (C\/EBP-delta) is induced in growth-arrested mouse mammary epithelial cells","author":"O'Rourke","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M004476200","article-title":"Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland","volume":"275","author":"Hutt","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.ebiom.2019.05.002_bb0245","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.celrep.2017.02.028","article-title":"Interrogation of functional cell-surface markers identifies CD151 dependency in high-grade serous ovarian Cancer","volume":"18","author":"Medrano","year":"2017","journal-title":"Cell Rep"},{"issue":"19","key":"10.1016\/j.ebiom.2019.05.002_bb0250","first-page":"4285","article-title":"Characterization of the & tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents","volume":"57","author":"Connor","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0255","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1038\/ncomms8419","article-title":"Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours","volume":"6","author":"Ince","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0260","doi-asserted-by":"crossref","first-page":"12642","DOI":"10.1038\/srep12642","article-title":"Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin \u03b24 and Akt signals","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2019.05.002_bb0270","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(16)48496-7","article-title":"Cyclic changes in ciliation, cell height, and mitotic activity in human tubal epithelium during reproductive life","volume":"43","author":"Donnez","year":"1985","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ebiom.2019.05.002_bb0275","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/oxfordjournals.humrep.a138428","article-title":"Physiology: morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause","volume":"9","author":"Julie Crow","year":"1994","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ebiom.2019.05.002_bb0280","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0015-0282(16)39253-6","article-title":"Scanning Electron microscopic study of the human fallopian tube. Report II. Fetal life, reproductive life, and Postmenopause","volume":"23","author":"Patek","year":"1972","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ebiom.2019.05.002_bb0285","doi-asserted-by":"crossref","first-page":"e1334","DOI":"10.1371\/journal.pone.0001334","article-title":"The Cebpd (C\/EBPd) gene is induced by luteinizing hormones in ovarian Theca and interstitial cells but is not essential for mouse ovary function","author":"Huang","year":"2007","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2019.05.002_bb0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M","article-title":"E-cadherin and \u03b1-, \u03b2-, and \u03b3-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions","volume":"192","author":"Davidson","year":"2000","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.05.002_bb0295","first-page":"1765","article-title":"Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt","volume":"66","author":"ElMoneim","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fonc.2012.00033","article-title":"Epithelial-mesenchymal transition in ovarian carcinoma","volume":"2","author":"Davidson","year":"2012","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","article-title":"MicroRNA regulation of RNA virus replication and pathogenesis","volume":"23","author":"Trobaugh","year":"2017","journal-title":"Trends Mol Med"},{"issue":"18","key":"10.1016\/j.ebiom.2019.05.002_bb0310","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1158\/0008-5472.CAN-07-1585","article-title":"MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth","volume":"67","author":"Corney","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0315","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bcab.2018.08.010","article-title":"Computational analysis of micro RNAs compatibility in pharmacogenomic based regulatory networks of psoriatic arthritis: an initiation towards identifying a potential miRNA to treat psoriatic arthritis","volume":"16","author":"Anandaram","year":"2018","journal-title":"Biocatal Agric Biotechnol"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncb2173","article-title":"p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs","volume":"13","author":"Chang","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"16","key":"10.1016\/j.ebiom.2019.05.002_bb0325","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fonc.2017.00145","article-title":"Epithelial-to-Mesenchymal transition in the female reproductive tract: from Normal functioning to disease pathology","volume":"7","author":"Bilyk","year":"2017","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.ebiom.2019.05.002_bb0335","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/abbs\/gmu089","article-title":"Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R","volume":"46","author":"Xu","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"5","key":"10.1016\/j.ebiom.2019.05.002_bb0340","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s13277-014-2950-5","article-title":"Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer","volume":"36","author":"Yu","year":"2015","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.05.002_bb0345","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"issue":"18","key":"10.1016\/j.ebiom.2019.05.002_bb0350","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.4161\/cc.8.18.9537","article-title":"Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1 AU - Evdokimova","volume":"8","author":"Tognon","year":"2009","journal-title":"Valentina Cell Cycle"},{"issue":"5","key":"10.1016\/j.ebiom.2019.05.002_bb0355","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.172421","article-title":"Collective cell migration without proliferation: density determines cell velocity and wave velocity","volume":"5","author":"Tlili","year":"2018","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0360","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-03-3619","article-title":"CCAAT\/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells","volume":"65","author":"Ikezoe","year":"2005","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.ebiom.2019.05.002_bb0365","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1073\/pnas.0913813107","article-title":"C\/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27\/APC3 expression","volume":"107","author":"Pawar","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2019.05.002_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.05.002_bb0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.05.002_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ki.2015.21","article-title":"Inflammation and hypoxia linked to renal injury by CCAAT\/enhancer-binding protein \u03b4","volume":"88","author":"Yamaguchi","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ebiom.2019.05.002_bb0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/cdd.2010.94","article-title":"Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial\u2013mesenchymal transition in immortalized prostate cells","volume":"18","author":"Kogan-Sakin","year":"2011","journal-title":"Cell Death Differ"},{"issue":"31","key":"10.1016\/j.ebiom.2019.05.002_bb0390","doi-asserted-by":"crossref","first-page":"31069","DOI":"10.18632\/oncotarget.5209","article-title":"CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0395","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial Mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2019.05.002_bb0400","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1038\/s41467-018-07130-z","article-title":"Genetic dissection of the miR-200\u2013Zeb1 axis reveals its importance in tumor differentiation and invasion","volume":"9","author":"Title","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2019.05.002_bb0405","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/jcb.25818","article-title":"MiR-193b mediates CEBPD-induced Cisplatin sensitization through targeting ETS1 and Cyclin D1 in human Urothelial carcinoma cells","volume":"118","author":"Lin","year":"2017","journal-title":"J Cell Biochem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419303032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T22:00:37Z","timestamp":1742335237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419303032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":81,"alternative-id":["S2352396419303032"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.002","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCAAT\/enhancer binding protein delta (C\/EBP\u03b4) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}